Tessa Quinn
PPS-Exempt Cancer Hospitals, or PCHs, refer to specialized cancer hospitals that are exempt from the Medicare Prospective Payment System (PPS). This exemption was established by Congress in 1983 to address the financial challenges faced by hospitals exclusively serving oncology patients under the PPS system. The PPS system uses predetermined prices based on diagnosis-related groups, but dedicated cancer hospitals incur significant costs for specialized care, intensive services, expensive technology, and personnel. By receiving Medicare payments on a reasonable cost basis, PPS-exempt cancer hospitals can sustain their critical work in cancer treatment, research, and education, delivering better outcomes and lower mortality rates for patients with cancer. The PCHQR program was also developed to provide consumers with quality-of-care information and encourage hospitals to improve inpatient care for Medicare beneficiaries.
| Characteristics | Values |
|---|---|
| Purpose | To ensure the financial viability of specialized cancer hospitals that exclusively serve oncology patients |
| Reasoning | Cancer hospitals cannot generate revenue from better-reimbursed, non-cancer diagnosis-related groups (DRGs) to offset significantly under-reimbursed cancer-related DRGs |
| Medicare Payments | Payments are made on a reasonable cost basis, which is still less than the actual cost of care delivered |
| Outcome | Lower mortality rates compared to other cancer centers, with improved survival rates and lower rates of sepsis, acute renal failure, pulmonary failure, and urinary tract infections |
| Number of Hospitals | 11 hospitals have been granted PPS-Exempt Cancer Hospital designation |
| PCHQR Program | Provides consumers with quality-of-care information to make informed decisions and encourages hospitals to improve inpatient care quality |
Explore related products
![The Hospital [DVD]](https://m.media-amazon.com/images/I/61oQ2sBPcmL._AC_UY218_.jpg)
What You'll Learn
The exemption from Medicare PPS
The Prospective Payment System (PPS) is a payment methodology established by the Social Security Amendments Act in 1983, which uses predetermined prices based on diagnosis-related groups (DRGs) for inpatient claims. However, Congress recognised that this new payment methodology did not adequately capture costs for certain specialised hospitals, including 11 teaching hospitals primarily involved in cancer research and treatment. These hospitals became known as PPS-Exempt Cancer Hospitals (PCHs).
The exemption from the Medicare PPS was established to ensure the financial viability of specialised cancer hospitals that exclusively serve oncology patients. This is because, unlike general hospitals, they cannot generate revenue from better-reimbursed, non-cancer DRGs to offset the significantly under-reimbursed cancer-related DRGs. This is due to the lack of more profitable services, such as non-oncologic orthopaedic or cardiac surgery.
To address this issue, PPS-exempt centres receive Medicare payments based on a reasonable cost basis, although this is still less than the actual cost of the care delivered. The exemption helps to moderate the ongoing losses sustained by these institutions for their care of Medicare patients, allowing them to continue their critical work in cancer treatment, research, and education. The federal financial protection provided through PPS exemption has played a pivotal role in sustaining these institutions and advancing oncology care, research, and education.
The PPS-Exempt Cancer Hospital Quality Reporting (PCHQR) Program was developed as mandated by Section 3005 of the Affordable Care Act. The program aims to equip consumers with quality-of-care information to make more informed decisions about healthcare options. It also encourages hospitals and clinicians to improve the quality of care.
Best Hospitals: Shands and Beyond
You may want to see also
Explore related products
Improved survival rates
The exemption from the Medicare Prospective Payment System (PPS) was established by Congress in 1983 to ensure the financial viability of specialized cancer hospitals that exclusively serve oncology patients. The exemption functions to moderate the ongoing losses sustained by these institutions for their care of Medicare patients, allowing them to continue their critical work in cancer treatment, research, and education.
The existing medical literature demonstrates that PPS-exempt centers deliver comparatively better outcomes. For instance, Pfister et al found large survival differences between different types of hospitals treating Medicare patients with cancer. Mortality rates for patients treated at PPS-exempt hospitals were lower than at National Cancer Institute-designated comprehensive cancer centers, academic medical centers, and community hospitals. This pattern persisted across all cancer types, annually and cumulatively, and continued for at least 5 years post-treatment. Merkow et al also reported a clear trend toward improved survival, with significantly lower rates of sepsis, acute renal failure, pulmonary failure, and urinary tract infections at PPS-exempt hospitals.
Improved screening has also played a role in improving cancer survival rates. Early-stage cancers are now more likely to be detected, increasing the chances of successful treatment. The use of the human papillomavirus (HPV) vaccine as a cancer prevention tool has also helped lower the nation's cancer mortality rate.
The overall cancer survival rate has improved over the years. For example, the overall 5-year survival rate was 49% in the mid-1970s, improving to 68% overall by 2024. The 5-year relative survival rate for all cancers combined improved from 58% in the mid-1970s to 85% during 2012-2018 for children, and from 68% to 86% for adolescents. For patients diagnosed with cancer in 2016, 71.7% survived the cancer for at least five years.
The country's cancer death rate has also declined by 33% since its peak in 1991, largely due to cancer research leading to new treatments, gains in early cancer detection, and a sharp decline in tobacco use.
Hospitals' Duty: Adverse Event Reporting Requirements
You may want to see also
Better patient outcomes
PPS-Exempt Cancer Hospitals, also known as Prospective Payment System (PPS)-Exempt Cancer Hospitals, are excluded from payment under the Inpatient Prospective Payment System. The exemption was established by Congress in 1983 to ensure the financial viability of specialized cancer hospitals that exclusively serve oncology patients.
These hospitals are disadvantaged by the PPS because they cannot generate revenue from better-reimbursed, non-cancer diagnosis-related groups (DRGs) to offset the significantly under-reimbursed cancer-related DRGs. This is because dedicated cancer hospitals lack more profitable services such as non-oncologic orthopedic or cardiac surgery.
To address this, PPS-exempt centers receive Medicare payments on a reasonable cost basis, which is still less than the actual cost of care delivered. The exemption helps to moderate the ongoing losses sustained by these institutions for their care of Medicare patients, allowing them to continue their critical work in cancer treatment, research, and education.
The federal financial protection provided to dedicated cancer hospitals through PPS exemption has played a pivotal role in sustaining their essential work in advancing oncology care, research, and education. Medical literature demonstrates that PPS-exempt centers deliver comparatively better outcomes. For example, studies have found that mortality rates for patients treated at PPS-exempt hospitals were lower than at National Cancer Institute-designated comprehensive cancer centers, academic medical centers, and community hospitals. Additionally, there were significantly lower rates of sepsis, acute renal failure, pulmonary failure, and urinary tract infections at PPS-exempt hospitals.
Hospital Sleep Test: What to Expect
You may want to see also
Quality-of-care information
One example of a quality indicator is hospital accreditation status, such as approval by the American College of Surgeons' Commission on Cancer. Additionally, consumers can look for hospitals that are voluntarily inspected or reviewed, as these hospitals generally meet minimum standards for infection control, safety, and security. When choosing a physician, individuals can look for certification by a cancer specialty board, which indicates completion of an approved training program and passing of rigorous exams. Other potential indicators of physician quality include disciplinary history, hospital admitting privileges, and the volume of cancer patients treated.
Large clinical trials play a crucial role in establishing links between specific processes of care or treatments and optimal outcomes, such as survival and enhanced quality of life. Early detection through screening has been shown to significantly reduce mortality, as evidenced by the impact of screening mammography on breast cancer survival rates. Health services research also contributes to defining high-quality care, and observations of current medical practices can reveal the extent to which effective care is being applied.
The volume-outcome relationship is another important consideration in quality cancer care. Studies have consistently shown that treatment in higher-volume hospitals is associated with better short-term survival rates and improved outcomes for various types of cancer, including pancreatic cancer and breast cancer. This relationship is particularly strong for technically difficult procedures, such as esophageal surgery or complex chemotherapy regimens. Therefore, individuals undergoing these procedures should seek care at high-volume facilities with extensive experience.
In terms of PPS-exempt cancer hospitals, the exemption from the Medicare Prospective Payment System (PPS) was established by Congress to ensure the financial viability of specialized cancer hospitals. PPS-exempt centers receive Medicare payments based on reasonable costs, moderating the losses sustained in caring for Medicare patients. Research has shown that PPS-exempt hospitals deliver comparatively better outcomes, with lower mortality rates and reduced rates of sepsis, acute renal failure, pulmonary failure, and urinary tract infections.
Staying Strong: Tips to Avoid Tears in Hospitals
You may want to see also
Higher costs of services
PPS-exempt cancer hospitals, also known as PCHs, are specialised cancer hospitals that were exempted from the Medicare Prospective Payment System (PPS) by Congress in 1983. This exemption was put in place to ensure the financial viability of these hospitals, as they could not generate revenue from non-cancer-related services like non-oncologic orthopaedic or cardiac surgery to offset the under-reimbursed cancer-related diagnosis-related groups (DRGs).
The higher costs of services at PPS-exempt cancer hospitals can be attributed to several factors. Firstly, these hospitals provide cutting-edge cancer therapies and treatments that are more expensive than those offered by non-exempt hospitals. The GAO analysis in 2015 highlighted that Medicare payments for radiation services, such as intensity-modulated radiation therapy (IMRT), were higher at PPS-exempt hospitals due to the additional payments allowed under the exemption program. This resulted in overall higher payments for outpatient services compared to non-exempt hospitals.
Secondly, PPS-exempt cancer hospitals often have higher operating costs due to their focus on specialised cancer care and research. The Alliance for Dedicated Cancer Centers, representing PCHs, argued that these hospitals undertake more care in the outpatient setting, which can save costs by reducing inpatient admissions. However, the specialised nature of their services and the need to stay at the forefront of cancer treatment and innovation contribute to higher overall expenses.
Additionally, PPS-exempt cancer hospitals may have higher overhead costs related to staffing, equipment, and facilities. They require highly trained oncology specialists, advanced medical equipment, and purpose-built facilities to deliver state-of-the-art cancer treatment. These factors can drive up the overall cost of services provided by these hospitals.
Moreover, the methodology used to calculate reimbursement for PPS-exempt cancer hospitals is based on historical cost data, which may not accurately reflect the current expenses incurred by these hospitals. This can lead to a discrepancy between the actual cost of providing cancer care and the reimbursement received, contributing to higher costs of services.
Despite the higher costs, PPS-exempt cancer hospitals have demonstrated improved outcomes and lower mortality rates compared to other cancer treatment centres. This suggests that the additional expenses may be justified by the enhanced quality of care and better patient outcomes achieved at these specialised hospitals.
Car Seat Safety: Hospitals and Expiration Dates
You may want to see also
Frequently asked questions
PPS-Exempt Cancer Hospitals, also known as PCHs, are hospitals that have been exempted from the Medicare Prospective Payment System (PPS).
The exemption was established by Congress in 1983 to ensure the financial viability of specialized cancer hospitals that exclusively serve oncology patients.
PPS-exempt centers receive Medicare payments on a reasonable cost basis, which is still less than the actual cost of care delivered. This helps moderate the ongoing losses sustained by these institutions for their care of Medicare patients.
The PCHQR program was developed as mandated by the Affordable Care Act to equip consumers with quality-of-care information to make informed decisions about healthcare options. It also encourages hospitals and clinicians to improve the quality of inpatient care provided to Medicare beneficiaries.
